Schonfeld Strategic Advisors’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.45M | Sell |
37,548
-37,444
| -50% | -$2.44M | 0.02% | 794 |
|
|
2025
Q1 | $5.02M | Buy |
+74,992
| New | +$5.02M | 0.03% | 461 |
|
|
2024
Q1 | – | Sell |
-3,831
| Closed | -$211K | – | 1856 |
|
|
2023
Q4 | $211K | Sell |
3,831
-27,969
| -88% | -$1.54M | ﹤0.01% | 1435 |
|
|
2023
Q3 | $1.85M | Sell |
31,800
-18,200
| -36% | -$1.06M | 0.01% | 740 |
|
|
2023
Q2 | $2.69M | Buy |
50,000
+20,250
| +68% | +$1.09M | 0.02% | 660 |
|
|
2023
Q1 | $1.18M | Sell |
29,750
-10,096
| -25% | -$401K | 0.01% | 876 |
|
|
2022
Q4 | $1.6M | Buy |
+39,846
| New | +$1.6M | 0.01% | 914 |
|